Eton Pharmaceuticals Inc (ETON)
3.70
+0.07
(+1.93%)
USD |
NASDAQ |
May 15, 15:23
Eton Pharmaceuticals Total Liabilities (Quarterly): 15.30M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 15.30M |
December 31, 2023 | 16.26M |
September 30, 2023 | 14.63M |
June 30, 2023 | 14.21M |
March 31, 2023 | 12.69M |
December 31, 2022 | 11.95M |
September 30, 2022 | 10.34M |
June 30, 2022 | 9.804M |
March 31, 2022 | 9.813M |
December 31, 2021 | 9.835M |
September 30, 2021 | 10.95M |
June 30, 2021 | 9.17M |
March 31, 2021 | 9.631M |
Date | Value |
---|---|
December 31, 2020 | 10.66M |
September 30, 2020 | 10.01M |
June 30, 2020 | 7.528M |
March 31, 2020 | 6.621M |
December 31, 2019 | 6.522M |
September 30, 2019 | 1.159M |
June 30, 2019 | 1.545M |
March 31, 2019 | 3.775M |
December 31, 2018 | 2.024M |
September 30, 2018 | 2.774M |
June 30, 2018 | 2.15M |
March 31, 2018 | 1.55M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.159M
Minimum
Sep 2019
16.26M
Maximum
Dec 2023
9.931M
Average
9.921M
Median
Total Liabilities (Quarterly) Benchmarks
Eli Lilly and Co | 51.05B |
Evoke Pharma Inc | 9.648M |
Outlook Therapeutics Inc | 46.03M |
NovaBay Pharmaceuticals Inc | 5.197M |
Palatin Technologies Inc | 24.94M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 30.79M |
Shareholders Equity (Quarterly) | 15.49M |
Debt to Equity Ratio | 0.324 |
Current Ratio | 1.586 |
Net Debt Paydown Yield | 0.29% |